Six unknown compounds were discovered in Clematis chinensis, along with known compounds. Some compounds showed significant anti-inflammatory activity, reducing the secretion of inflammatory factors by inhibiting the NF-κB signaling pathway.
Researchers investigated the effects of a botanical drug derived from three plants on schizophrenia-like behaviors induced by MK-801. The drug has been used to treat rheumatoid arthritis in Korea. The study found that the herbal complex extract improved cognitive function and reduced the symptoms of schizophrenia-like behaviors in mice. These results suggest that the botanical drug could potentially be used to treat schizophrenia in humans.